Analysis of survival-related factors in patients with endometrial cancer using a Bayesian network model
- PMID: 39570902
- PMCID: PMC11581279
- DOI: 10.1371/journal.pone.0314018
Analysis of survival-related factors in patients with endometrial cancer using a Bayesian network model
Abstract
Background: In recent years, remarkable progress has been made in the use of machine learning, especially in analyzing prognosis survival data. Traditional prediction models cannot identify interrelationships between factors, and the predictive accuracy is lower. This study aimed to construct Bayesian network models using the tree augmented naïve algorithm in comparison with the Cox proportional hazards model.
Methods: A Bayesian network model and a Cox proportional hazards model were constructed to analyze the prognostic factors of endometrial cancer. In total, 618 original cases obtained from the Surveillance, Epidemiology, and End Results database were used to construct the Bayesian network model, which was compared with the traditional Cox proportional hazards model by analyzing prognostic factors. External validation was performed using a dataset from The First Affiliated Hospital of Shandong First Medical University.
Results: The predictive accuracy, area under the receiver operating characteristic curve, and concordance index for the Bayesian network model were 74.68%, 0.787, and 0.72, respectively, compared to 68.83%, 0.723, and 0.71, respectively, for the Cox proportional hazards model. Tumor size was the most important factor for predicting survival, followed by lymph node metastasis, distant metastasis, chemotherapy, lymph node resection, tumor stage, depth of invasion, tumor grade, histological type, age, primary tumor site, radiotherapy and surgical sequence, and radiotherapy.
Conclusion: The findings indicate that the Bayesian network model is preferable to the Cox proportional hazards model for predicting survival in patients with endometrial cancer.
Copyright: © 2024 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures






Similar articles
-
Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort.Clin Transl Oncol. 2024 Dec;26(12):3169-3190. doi: 10.1007/s12094-024-03513-5. Epub 2024 Jun 4. Clin Transl Oncol. 2024. PMID: 38834909 Free PMC article.
-
Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.World J Gastroenterol. 2019 Oct 7;25(37):5655-5666. doi: 10.3748/wjg.v25.i37.5655. World J Gastroenterol. 2019. PMID: 31602165 Free PMC article.
-
Integration of pretreatment tumor markers in a nomogram model for prognostic prediction of FIGO stage I endometrial cancer: A multi-institutional cohort study.Int J Gynaecol Obstet. 2024 Jun;165(3):1244-1256. doi: 10.1002/ijgo.15362. Epub 2024 Jan 29. Int J Gynaecol Obstet. 2024. PMID: 38287783
-
Prediction of all-cause death and specific causes of death in patients with gastric cancer with liver metastasis: a Surveillance, Epidemiology, and End Results-based study.J Gastrointest Surg. 2024 Jun;28(6):880-888. doi: 10.1016/j.gassur.2024.03.019. Epub 2024 Mar 18. J Gastrointest Surg. 2024. PMID: 38616463
-
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46. doi: 10.1002/ssu.2980100107. Semin Surg Oncol. 1994. PMID: 8115784 Review.
Cited by
-
Prognostic risk modeling of endometrial cancer using programmed cell death-related genes: a comprehensive machine learning approach.Discov Oncol. 2025 Mar 8;16(1):280. doi: 10.1007/s12672-025-02039-8. Discov Oncol. 2025. PMID: 40056247 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources